ImmunXperts, a Q2 Solutions company, is a specialized CRO focused on providing comprehensive immunogenicity and immunotoxicity testing services for biologics and biosimilars. Utilizing cell-based in vitro assays and human primary cells, ImmunXperts assists biopharmaceutical developers in assessing the safety and immune-modulating profiles of therapeutic candidates prior to clinical entry.